Revolution Medicines, Inc. (RVMD) Misses Q4 EPS by 28c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q4 EPS of ($1.86), $0.28 worse than the analyst estimate of ($1.58).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• JPMorgan cut off lending activity for Situational Awareness - FT
• GMR Solutions to reprice $2.9B term loan, pay down $200M in debt